Brief: LumiraDx Announces Pricing Of Public Offering Of Common Shares And Concurrent Private Placement
July 21 (Reuters) - LumiraDx Ltd LMDX.O :
* LUMIRADX ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON SHARES AND
CONCURRENT
PRIVATE PLACEMENT
* LUMIRADX LTD - PRICING OF UNDERWRITTEN PUBLIC OFFERING OF 43 MILLION
COMMON
SHARES AT A PRICE TO PUBLIC OF $1.75 PER SHARE
* LUMIRADX - AGREED TO SELL ADDITIONAL 14.3 MILLION COMMON SHARES TO RAISE
GROSS
PROCEEDS OF ABOUT $25.0 MILLION IN CONCURRENT PRIVATE PLACEMENT AT $1.75/SHARE
* LUMIRADX LTD - AGREED TO SELL ADDITIONAL 14.3 MILLION COMMON SHARES TO ONE
OF
ITS EXISTING INVESTORS, BILL & MELINDA GATES FOUNDATION
Source text for Eikon: ID:nPn4LKLLJa
Further company coverage: LMDX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on LumiraDx
See all newsBrief: LumiraDx Announces Its Securities Will Be Suspended From Trading On Nasdaq At The Open Of Business On January 9Th
Roche to buy part of LumiraDx diagnostics platform for $295 million
Brief: LumiraDx- Under Terms Of Certain Loan Agreement, Dated March 23, 2021, The Waiver Period Has Expired As Of Today
Brief: LumiraDx Announces Agreement to Sell its Cutting Edge Point of Care Technology Platform to Roche
Brief: Willard L. Umphrey Reports 10.31% Stake In Lumiradx Limited As Of Dec 22- SEC Filing